Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9CDM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,490
Award facts
- Contract value 100% obligated
- $30,489.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30.5K delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on December 29, 2025, with a completion date of December 30, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier to federal medical procurement. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's extensive pharmaceutical distribution capabilities to support military and federal healthcare systems.
This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $1 billion prime vendor agreement valued through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies globally. AmerisourceBergen's federal contract portfolio demonstrates consistent performance in delivering brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. BIKTARVY is an HIV treatment medication, reflecting the company's role in supplying specialized pharmaceutical products for military personnel and federal beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F9CDM?
SPE2DR26F9CDM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F9CDM worth?
The government has obligated $30,490 on SPE2DR26F9CDM.
Is contract SPE2DR26F9CDM an order under another contract?
Yes. SPE2DR26F9CDM is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CDM competed?
The extent of competition for SPE2DR26F9CDM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award